In 19 obese, diabetic uric acid stone formers, phentermine/topiramate vs pragmatic control did not significantly reduce CT stone volume by intention to treat (−52% vs +8.6%, P=.10); per-protocol reduction was significant (P=.02). Feasibility trial.
RCTn = 19
Canales et al. Phentermine/Topiramate in Obese, Diabetic Uric Acid Stone Formers: An Open-Label Randomized Feasibility Trial